The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation
Clinical trial NCT02820116 · UNKNOWN
Trial details
- NCT number
- NCT02820116
- Sponsor
- Beijing Haidian Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2023-04-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.